TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $718,136,000 | -24.2% | 39,458 | -25.7% | 0.51% | -17.2% |
| Q3 2020 | $947,161,000 | -0.5% | 53,092 | 0.0% | 0.62% | -36.7% |
| Q2 2020 | $951,940,000 | +18.1% | 53,092 | 0.0% | 0.98% | -37.6% |
| Q1 2020 | $805,937,000 | -23.1% | 53,092 | 0.0% | 1.57% | +22.1% |
| Q4 2019 | $1,047,505,000 | -2.8% | 53,092 | -15.2% | 1.29% | +55.6% |
| Q3 2019 | $1,077,374,000 | -78.3% | 62,638 | -77.6% | 0.83% | -62.4% |
| Q2 2019 | $4,956,000,000 | -43.5% | 280,000 | -34.9% | 2.20% | -48.4% |
| Q1 2019 | $8,766,617,000 | -44.2% | 430,369 | -53.9% | 4.26% | -53.7% |
| Q4 2018 | $15,700,898,000 | – | 933,466 | – | 9.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |